Pfizer adds second Phase 3 berobenatide knee osteoarthritis trial, completes Phase 2b VESPER-3Nov 6Weekly roundup, 13 itemsberobenatidemarstacimab-hncqUpdated
Pfizer week: AML donor-leukocyte trial posts results; three early trials advanceJul 24Weekly roundup, 4 itemsgemtuzumab ozogamicinPF-08653945